Edwards completes enrollment in PARTNER 3 low-risk CT sub-study, updates launch timeline
Edwards announced that enrollment is complete in the CT imaging sub-study within the PARTNER 3 trial of the SAPIEN 3 valve. This randomized sub-study is examining leaflet mobility of both the SAPIEN 3 valve and surgical heart valves in low-risk patients undergoing valve replacement. March 21, 2018